McKesson Price Target Raised to $210.00 at FBR Capital Markets (MCK)
Equities researchers at FBR Capital Markets hoisted their price target on shares of McKesson (NYSE:MCK) from $200.00 to $210.00 in a research report issued on Thursday. The firm currently has an “outperform” rating on the stock. FBR Capital Markets’ target price indicates a potential upside of 9.45% from the stock’s previous close.
A number of other analysts have also recently weighed in on MCK. Analysts at Raymond James raised their price target on shares of McKesson from $210.00 to $220.00 in a research note on Tuesday, July 1st. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of McKesson in a research note on Thursday, June 26th. They now have a $205.00 price target on the stock, up previously from $197.00. Finally, analysts at Mizuho raised their price target on shares of McKesson from $199.00 to $205.00 in a research note on Thursday, June 26th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. McKesson has an average rating of “Buy” and a consensus target price of $203.73.
McKesson (NYSE:MCK) traded up 0.32% on Thursday, hitting $191.86. 2,543,320 shares of the company’s stock traded hands. McKesson has a 1-year low of $120.17 and a 1-year high of $195.20. The stock has a 50-day moving average of $188.1 and a 200-day moving average of $178.9. The company has a market cap of $44.238 billion and a P/E ratio of 35.30.
McKesson (NYSE:MCK) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.49 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.36 by $0.13. The company had revenue of $44.06 billion for the quarter, compared to the consensus estimate of $40.65 billion. During the same quarter in the prior year, the company posted $2.07 earnings per share. The company’s quarterly revenue was up 36.7% on a year-over-year basis. Analysts expect that McKesson will post $10.66 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 1st. Investors of record on Tuesday, September 2nd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 0.50%.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.